A Sub Study to Investigate the Safety and Tolerability of Aletekitug in Participants With Moderate To Severe Ulcerative Colitis

Clinical trial NCT07747480 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07747480
Sponsor: GlaxoSmithKline
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Colitis, Ulcerative

Start date: 2026-08-10
Primary completion: 2028-07-31
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.